Price target
69.210.000.00%
The 14 analysts offering 1 year price forecasts for CRNX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 14 analysts giving stock ratings to CRNX in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CRNX EPS for the last quarter is −0.94 USD despite the estimation of −0.86 USD. In the next quarter EPS is expected to reach −0.91 USD. Track more of Crinetics Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Crinetics Pharmaceuticals, Inc. revenue is expected to reach 218.09 K USD. Check out Crinetics Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, CRNX price target is 69.21 USD with a max estimate of 97.00 USD and a min estimate of 48.00 USD. Check if this forecast comes true in a year, meanwhile watch Crinetics Pharmaceuticals, Inc. stock price chart and keep track of the current situation with CRNX news and stock market news.
We've gathered opinions of 14 analysts rating CRNX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.